ACP Pharma S.A.

Other News To Note.
BIOWORLD Today; 11/4/2009; 2934 words; ...as well as Adherex's third-generation, small...Pharmaceutical Inc.'s AG7088 was a subject in...Pfizer Inc. o Altachem Pharma Ltd., of Edmonton, Alberta...commence a Phase I trial of ACP-HIP in Kaposi's sarcoma. ACP-HIP is...

ACAD, PKOH, MIP, UWBK, PRCP and FLL Expected To Be Lower After Earnings Releases on Monday.
M2 Presswire; 5/7/2009; 3639 words; ...Molecular Insight Pharma (NASDAQ: MIPI...vital to the market's perception of the vitality...development for Parkinson's disease psychosis...Inc., as well as ACP-106 in IND-track...pipeline also consists of ACP-105 for endocrine...compounds for Parkinson's disease. It has a...

Zacks Analyst Blog Highlights: AutoNation, Inc., Oscient Pharmaceuticals Corp., Equity Residential, ACADIA Pharmaceuticals Inc. and Allergan, Inc.
Business Wire; 10/3/2008; 1554 words; ...impact on the company's growth prospects. Equity...estate operator in the U.S. The housing market has...couple of quarters. Acadia Pharma Lacking Catalysts Acadia...program with pimavanserin (ACP-103) for treatment...dysfunction in Parkinson's disease. Other potential...

Acadia Pharma Lacking Catalysts.
Zacks; 10/2/2008; 762 words; ...program with pimavanserin (ACP-103) for treatment-induced dysfunction in Parkinson's disease. Other potential...After the failure of the ACP-104 program and the lack...for schizophrenia, Acadia's stock has been hit hard...

Acadia Pharma Lacking Catalysts - Analyst Blog
Zacks Investment Research - Analyst Blog; 10/1/2008; 393 words; Acadia Pharma Lacking Catalysts - Analyst...program with pimavanserin (ACP-103) for treatment...dysfunction in Parkinson's disease. Other potential...After the failure of the ACP-104 program and the...schizophrenia, Acadia's stock has been hit hard...